Nature Reviews Endocrinology

Article	Citations
Exposing skin to ultraviolet irradiation increases food intake in male individuals	972
Immune cell population prevents weight regain	593
Non-nutritive sweeteners — too sweet to be wholesome?	549
Timed high-fat diet feeding restores small bowel circadian rhythms	530
Memory of obesity stored in adipocytes	322
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	271
The role of DNA damage in diabetic complications	241
Author Correction: Adrenocortical stem cells in health and disease	241
The challenges of assessing adiposity in a clinical setting	236
Effects of diet on atherosclerotic plaque development	224
Limiting the use and misuse of liothyronine in hypothyroidism	199
Thyroid function and iodine intake: global recommendations and relevant dietary trends	194
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	189
The gut microbiota in obesity and weight management: microbes as friends or foe?	182
Ketosis improves muscle stem cell resilience	158
Patients’ insights into diabetes insipidus	148
Neurons in the diagonal band of Broca moderate food intake	146
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines	144
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’	144
Obesity phenotypes: explaining the unexplained	139
Midlife and the menopause transition in type 2 diabetes mellitus prevention	137
A pivotal year for NAFLD and NASH therapeutics	129
Reply to ‘Why the science on T3 and genomics is not settled’	122
Fusion with blood vessel organoids supports pancreatic islet function	121
Steroid hormones as modulators of anti-tumoural immunity	117

The interactions between energy homeostasis and neurovascular plasticity	109
mTORC1 is the central regulator in pancreatic β-cells	102
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity	101
Primary aldosteronism — a multidimensional syndrome	95
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus	92
New maps and new challenges in the post-genomic era	87
New role for bone marrow adipocytes in obesity	87
A role for the kidney in metformin action	87
RalA links obesity and mitochondrial dysfunction	87
Genetic risk scores improve prediction of obesity in survivors of childhood cancer	87
The metabolic mythos of ketones	86
Advances in basic biology and translation in islet research	86
Inflammation-induced adrenal dysfunction	84
Epigenetic effects of maternal type 1 diabetes mellitus	83
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption	82
Advances in incretin-based therapeutics for obesity	80
Targeting the incretin system in obesity and type 2 diabetes mellitus	78
Language evolves — so can you	78
Endosomal trafficking in metabolic homeostasis and diseases	76
Luteal phase support in assisted reproductive technology	76
Endocrinologists gather at ECE 2026	75
Dysfunctional adipose tissue–lymphatic crosstalk in obesity	75
Bone and muscle crosstalk in ageing and disease	73
Untangling the pathways of SDHx loss of function	72
Author Correction: Drug Insight: selective agonists and antagonists of the glucocorticoid receptor	71
Leptin–thyroid hormone axis affects energy use in muscle	70
REG3G — a potential link between the intestinal microbiome and host physiology	68
Tracing the biological roots of obesity resistance in humans	68
Iatrogenic adrenal insufficiency in adults	66
Potential downsides of calorie restriction	66
The metabolic benefits of exercise-induced hepatic autophagy	66
Islet hormones at the intersection of glucose and amino acid metabolism	60
The role of ultra-processed food in obesity	60
A global view of hypertensive disorders and diabetes mellitus during pregnancy	58
Length of light exposure alters energy metabolism in mice	55
From the perspective of a scientist with Cushing disease, what did not kill me made my science stronger	54
GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating	51
Vitamin D supplementation and fracture risk	51
GPR110 as a regulator of MASH	51
The complexity of the relationship between thyroid disease and body weight	50
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?	50
Metabolic control of feto–placental development and pregnancy outcomes	49
Obesity dysregulates a pituitary–liver axis through disruption of the unfolded protein response	49
Investigating the effects of artificial sweeteners	48
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice	48
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?	48
The autonomic nervous system in the regulation of glucose and lipid metabolism	45
Lipid droplet biogenesis and functions in health and disease	44
Sarcopenic obesity in older adults: a clinical overview	44
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus	43

Targeting senescent cells in ageing-related endocrine diseases	42
At the 2022 Congress on Obesity	42
Variation in serotonin 2C receptor linked with obesity and behaviour	42
Engineered Tregs prevent diabetes mellitus in mice	42
Energy intake at the intersection of the clock and ageing	41
ZMIZ1 supports endometrial oestrogen and progesterone signalling	40
Large study on hormone therapy for transgender youth provides reassurance amid treatment politicization	40
OBEClust: joining forces to prevent obesity	40
Metformin and GDF15: where are we now?	39
Mitigating the environmental effects of healthcare: the role of the endocrinologist	39
Highlights from SfE BES 2026	37
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency	36
The glymphatic system as a nexus between obesity and neurological diseases	36
Exercise in adults with type 1 diabetes mellitus	36
Growth hormone-releasing hormone and its analogues in health and disease	35
Sertoli cell lysosomal dysfunction drives age-related testicular degeneration	35
The regulation of endocrine-disrupting chemicals to minimize their impact on health	34
Advancing precision nutrition: bridging mechanistic insight and clinical implementation	34
Models of hyperglycaemia in diabetes mellitus and its complications	34
Medically not yet explained symptoms in hypothyroidism	34
Blood-based obesity biomarkers and their relevance for disease risk	34
New genes associated with adult-onset obesity	34
A mitochondrial trigger for beige adipocyte development	32
Can obesity pharmacotherapy be used to manage male infertility?	32
GWAS gives insights into glucose regulation	32
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia	32
Individualized and innovative gender healthcare for transgender and nonbinary youth	31
Diabetes mellitus and work participation	30
Interventions in people newly diagnosed with type 1 diabetes mellitus	30
Greater recognition required for thyroid disorders	29
Combination therapy increases human β-cell mass in vivo	29
Brown adipose tissue fights the battle against leukaemia	29
Metabolic effects of gender-affirming hormone therapy	29
The complex effects of dietary restriction on longevity and health	29
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss	29
Masterful papers that broke open understanding of reproductive neuroendocrinology	29
Highlights from ADA 85th Scientific Sessions	28
Knowledge in youth is wisdom in age: involving young people in research	27
The public health burden of diabetes mellitus and thyroid disease: twin epidemics	27
Negative effects of ultra-processed foods beyond increasing calories	27
Variation in metformin pharmacokinetics	26
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents	25
Exposure to fat odour during development predisposes offspring to obesity	25
Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation	24
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia	24
Sex differences in diabetic kidney disease explained	24
Peritumoural adipose tissue protects colorectal cancer from immune attack	24
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus	23
Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis	23
Highlights from ADA 82nd Scientific Sessions	22
AcroBATics: how dying brown adipocytes trigger browning	22
Antioxidant liver myeloid cell population identified	22
The study that pioneered islet isolation techniques	21
Obesity induces epigenetic memory in innate immune cells	20
Advances in incretin-based drug discovery in 2025	20
Author Correction: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits	20
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance	19
Bone fragility in type 2 diabetes mellitus: a lot left to explore	19
Skeletal stem and progenitor cells in bone physiology, ageing and disease	18
Genomics suggest role for IGF1 resistance in T2DM	17
New variant for monogenic obesity	17
CAMK1D required for ghrelin-mediated food intake	17
Consensus on acromegaly therapeutic outcomes: an update	17
Current and future pharmacotherapies for obesity in children and adolescents	16
Endoscopic sleeve gastroplasty: safe and effective	15
Antigen-specific Treg cells induce infectious tolerance	15
IL-17 has a role in whole-body homeostasis	15
The progesterone receptor’s journey through mouse models	15
Empowering early career researchers: academy-driven pathways to excellence	14
Thyroid dysfunction in COVID-19	14
The intersection between ghrelin, metabolism and circadian rhythms	14
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits	14
Translational perspectives from TSHR, MCT8 and TRα research	14
Endocrine regulation of the hepatic fasting response: cues, cooperation and consequences	14
Causes and consequences of discontinuation of GLP1RAs or tirzepatide	14
Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade	14
Causes of sarcopenia and frailty in people taking GLP1RAs	14
Metabolic and feeding adjustments during pregnancy	13
Human stomach tissue as alternative source of insulin-producing cells	13
Liothyronine treatment for hypothyroidism — a patient’s view	13

Pituitary stem cells: past, present and future perspectives	12
The interplay between diabetes mellitus and menopause: clinical implications	12
Bile acids in the crosshairs for hypoglycaemia after gastric bypass	12
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement	12
Deciphering the role of leptin in weight gain associated with anti-psychotic medications	12
How the WHIMS clinical trial shaped the future of women’s health research	11
The role of sweeteners in weight loss	11
Parental exercise mediates fetal metabolic and cardiac programming	11
Intricacies and obscurities of non-shivering thermogenesis	11
Driving hypertension: non-classic apparent mineralocorticoid excess	10
Endocrine effects of heat exposure and relevance to climate change	10
JNK at the helm: decoding obesity-driven insulin resistance	10
Modelling human liver disease: from steatotic liver disease to MASH-HCC	10
Bile acid species shows potential for NAFLD	10
Control loop designs in health and disease	10
A transporter on the move	10
Data-driven diabetes mellitus subtypes and precision care	10
A century of glucagon	9
Obesity-associated ASB4 controls satiety	9
Exploring the functions of the myokine feimin	9
Making a droplet: the adipogenin–seipin complex at work	9
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice	9
Brain–immune networks: a role for GLP1 receptor	9
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?	9
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus	8
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy	8
Nonenzymatic prevention of insulin hyperresponsiveness by FBP1	8
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer	8
Adrenal cysts: an emerging condition	8
The relationship between the gut microbiota and thyroid disorders	7
Oxytocin regulates adipose tissue lipolysis	7
Brain insulin action in women	7
Optimising stem cells for diabetes mellitus therapy	7
Succinate signalling regulates leptin production in adipocytes	7
Diet composition affects mitochondria trafficking in adipose tissue	7
Health equity in endocrinology	6
Sarcopenia and MASLD: novel insights and the future	6
Emerging mechanisms of obesity-associated immune dysfunction	6
Early life factors that affect obesity and the need for complex solutions	6
Genomic alterations in thyroid cancer: biological and clinical insights	6
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus	6
Defining subpopulations of human adipose tissue progenitor cells	6
Kidney diseases and the thyroid: interactions and consequences	6
Consensus Statement on the definition and classification of metabolic hyperferritinaemia	6
HDL metabolism and function in diabetes mellitus	6
The effect of hypoglycaemia on neurodevelopment: insights from congenital hyperinsulinism	5
Long-term and sequential treatment for osteoporosis	5
Cognitive function in T1DM improved by hybrid closed-loop insulin delivery	5
Metabolic elasticity — a new trait associated with health?	5
Ketogenic diet in cancer: insufficient stress response?	5
Approval of teplizumab: implications for patients	5
Metabolism and exercise: the skeletal muscle clock takes centre stage	5
Publisher Correction: Neuro–immuno–endocrinology of the skin: how environment regulates body homeostasis	5
Highlights from SfE BES 2023	5
Hyponatraemia in ageing	5
Adipose tissue in communication: within and without	5
Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus	5
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus	5
Debunking the myths of intermittent fasting	5
A new model predicts the best medication for patients with type 2 diabetes mellitus	5
Balancing weight and muscle loss in GLP1 receptor agonist therapy	5
Adipose tissue boosts muscle regeneration by supplying mesenchymal stromal cells	5
Polycystic ovary syndrome as a metabolic disease	4
Control of tuberal hypothalamic development and its implications in metabolic disorders	4
Promising findings in PTH replacement therapy trial	4
Reply to ‘Slowly progressive insulin dependent diabetes mellitus in type 1 diabetes endotype 2’	4
Mechanisms of diabetic kidney disease and established and emerging treatments	4
Reply to ‘The shift of therapeutic strategy for prolactinomas: surgery as the first-line option’	4
Obesity induces systemic insulin resistance via endothelium-specific insulin receptor inhibition	4
Prader–Willi syndrome corrected in human hypothalamic organoids	4
Engineering adipocytes for cancer treatment	4
Graves disease: latest understanding of pathogenesis and treatment options	4
Inceptor loss in mice with obesity	4
GDF15 boosts muscle energy burn	4
The launch of European Hormone Day and EUWIN	4
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification	4
Unpicking variation in response to exercise	4
FDA fast-track approval of belzutifan is a milestone in rare cancer therapy	4
Metabolic alliance: pharmacotherapy and exercise management of obesity	4
Macrophages support pancreatic development	4
Cold-induced BAT stunts tumour growth	4
Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications	4
CCN3 maintains bone density during lactation	4
Phase I results for AMG 133	4
Early-onset colorectal cancer as an emerging disease of metabolic dysregulation	4
T-bet+ B cells promote metabolic disease	4
A pipeline for identification and validation of brain targets for weight loss	4
Risk factors, management and consequences of severe menopausal vasomotor symptoms	4
A trio of trials on hormone receptor agonists for MASLD	4
Novel mechanisms of pain in painful diabetic neuropathy	3
Advances in cardiometabolic outcomes in polycystic ovary syndrome	3
Two roads to thermogenesis: vascular and parenchymal sympathetic innervation of brown adipose tissue	3
GIP regulates body weight via GABAergic neurons	3
Publisher Correction: Growth hormone-releasing hormone and its analogues in health and disease	3
Twenty years of progress in type 1 diabetes mellitus	3